Submitted by Anonymous (not verified) on 2 October 2024 - 12:49
Opinion/decision on a Paediatric investigation plan (PIP): Dupixent, dupilumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Dermatology, PIP number: P/0297/2023
Source: